Blake Johnson, Ph.D., is a Senior Medical Affairs Specialist with over a decade of experience in translational oncology research, focusing on biomarker discovery and clinical application. Blake co-founded Navaux, contributing to the development of a circulating Hepsin antigen assay, and held key positions as a Medical Science Liaison at Genentech and Director & Clinical Scientist at Stage I Diagnostics, Inc. With extensive expertise in pre-clinical and clinical research, Blake is currently the Director of Medical Affairs in Urologic Oncology at Merck and continues their academic journey at Ouachita Baptist University. They possess a Ph.D. in Biomedical Sciences from The University of Texas MD Anderson Cancer Center UTHealth Graduate School and a Master's degree in Human Molecular Genetics from the University of Aberdeen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices